Xtant Medical Holdings (XTNT) Debt to Equity (2016 - 2025)
Xtant Medical Holdings (XTNT) has disclosed Debt to Equity for 16 consecutive years, with $0.57 as the latest value for Q3 2025.
- On a quarterly basis, Debt to Equity rose 19.05% to $0.57 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.57, a 19.05% increase, with the full-year FY2024 number at $0.8, up 87.37% from a year prior.
- Debt to Equity was $0.57 for Q3 2025 at Xtant Medical Holdings, down from $0.71 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.8 in Q4 2024 to a low of $0.31 in Q3 2023.
- A 5-year average of $0.53 and a median of $0.52 in 2023 define the central range for Debt to Equity.
- Biggest YoY gain for Debt to Equity was 129.7% in 2021; the steepest drop was 72.0% in 2021.
- Xtant Medical Holdings' Debt to Equity stood at $0.5 in 2021, then decreased by 29.49% to $0.35 in 2022, then rose by 20.63% to $0.42 in 2023, then surged by 87.37% to $0.8 in 2024, then fell by 28.32% to $0.57 in 2025.
- Per Business Quant, the three most recent readings for XTNT's Debt to Equity are $0.57 (Q3 2025), $0.71 (Q2 2025), and $0.76 (Q1 2025).